May 17, 2022 / 08:35PM GMT
Brian Corey Abrahams - RBC Capital Markets, Research Division - Senior Biotechnology Analyst
Good afternoon, everyone. I'm Brian Abrahams, one of the senior biotech analysts at RBC Capital Markets. Our last session on day 1 of our health care conference is going to be featuring Karyopharm. Really happy to have with us their CEO, Richard Paulson; and their new Chief Medical Officer, Reshma Rangwala. So Richard and Reshma, thanks again for joining us, and it's great to see you guys in person.
Reshma Rangwala - Karyopharm Therapeutics Inc. - Chief Medical Officer
Absolutely.
Richard A. Paulson - Karyopharm Therapeutics Inc. - President, CEO & Director
Thank you for having us. It's wonderful to see people in person again.
Questions and Answers:
Brian Corey Abrahams - RBC Capital Markets, Research Division - Senior Biotechnology AnalystIndeed. So maybe just to start things off on the commercial side with XPOVIO, you've -- you successfully launched the drug into a